FDA Approval for Abstral (Fentanyl) Sublingual Tablets
Links shared publicly online about this topic.
- 589total visits
FDA Approval for Abstral (Fentanyl) Sublingual Tablets
View full resource at drugs.com
Tags: Pain, Cancer, Cancer Pain Medication, FDA, Duragesic, Actiq
Most Recently Shared on January 11, 2011 at 6:32 am By:
FDA Approval for Abstral (Fentanyl) Sublingual Tablets - http://bit.ly/fWcS5u
FDA Approval for Abstral (Fentanyl) Sublingual Tablets
drugs.com — “Abstral (fentanyl) is used for the treatment of breakthrough pain in cancer patients. Includes Abstral side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 11, 2011 at 5:14 am By:
Drugs and Devices OW OW Health
FDA Approval for Abstral (Fentanyl) Sublingual Tablets: Uppsala, January 10, 2011 - Orexo AB announces tod... http://bit.ly/gmQwZy #drug
Abstral transmucosal tablets approved for breakthrough cancer pain - ONA
oncologynurseadvisor.com — “Abstral (fentanyl transmucosal immediate-release tablets, from ProStrakan) has been approved by the FDA for the management of breakthrough pain in adult patients with cancer, 18 years old, who already use opioid pain medication around the clock and who need and are able to safely use high doses of an additional opioid medicine.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 10, 2011 at 4:17 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Abstral transmucosal tablets approved for breakthrough cancer pain http://goo.gl/fb/k5V7Q
FDA Approves Abstral for Cancer Breakthrough Pain
emaxhealth.com — “The U.S. Food and Drug Administration (FDA) has approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer.” View full resource at emaxhealth.com
Most Recently Shared on January 10, 2011 at 4:03 pm By:
RT @rlbates: FDA Approves Abstral for Cancer Breakthrough Pain http://bit.ly/dJWA8v
FDA Approves Opioid Analgesic To Help Cancer Patients Manage Pain
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer. Fentanyl immediate-release transmucosal medications are” View full resource at medicalnewstoday.com
Most Recently Shared on January 8, 2011 at 2:05 pm By:
MNT Drug Approvals Health News
FDA Approves Opioid Analgesic To Help Cancer Patients Manage Pain http://mnt.to/3PNf #regulatory
Medical News: FDA Okays Another Fentanyl Product - in Pain Management, Pain Management from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved another fentanyl transmucosal tablet, Abstral, as a Schedule II opioid to treat breakthrough cancer pain but is requiring prescribers to enroll in a Risk Evaluation” View full resource at medpagetoday.com
Most Recently Shared on January 8, 2011 at 12:12 am By:
FDA Okays Another Fentanyl Product http://bit.ly/dM7jPV
Newly Approved Opioid Aids in Cancer Pain
hcplive.com — “The FDA approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer.” View full resource at hcplive.com
Most Recently Shared on January 7, 2011 at 10:27 pm By:
Newly Approved Opioid Aids in Cancer Pain http://hcp.lv/e6ZSCO
Advertisement
